Head-To-Head Comparison: Alliqua BioMedical (ALQA) vs. Transenterix (TRXC)
Alliqua BioMedical (NASDAQ: ALQA) and Transenterix (NASDAQ:TRXC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitabiliy, valuation, risk and earnings.
Institutional and Insider Ownership
24.0% of Alliqua BioMedical shares are held by institutional investors. 15.2% of Alliqua BioMedical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This is a summary of current ratings and target prices for Alliqua BioMedical and Transenterix, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Alliqua BioMedical presently has a consensus price target of $1.58, indicating a potential upside of 505.25%. Transenterix has a consensus price target of $0.70, indicating a potential upside of 1.45%. Given Alliqua BioMedical’s stronger consensus rating and higher probable upside, equities analysts clearly believe Alliqua BioMedical is more favorable than Transenterix.
Earnings and Valuation
This table compares Alliqua BioMedical and Transenterix’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Alliqua BioMedical||$18.88 million||0.64||-$20.24 million||($0.96)||-0.27|
|Transenterix||$5.05 million||18.09||-$47.82 million||N/A||N/A|
Alliqua BioMedical has higher revenue and earnings than Transenterix.
This table compares Alliqua BioMedical and Transenterix’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Alliqua BioMedical beats Transenterix on 8 of the 11 factors compared between the two stocks.
About Alliqua BioMedical
Alliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company’s businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company’s commercial wound care portfolio consists of over four product categories, such as Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers TheraBond 3D Antimicrobial Barrier Systems and SilverSeal.
TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.
Receive News & Ratings for Alliqua BioMedical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliqua BioMedical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.